L2 Asset Management, LLC Gilead Sciences, Inc. Transaction History

L2 Asset Management, LLC

$359 Million
Q3 2024

A detailed history of L2 Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, L2 Asset Management, LLC holds 4,925 shares of GILD stock, worth $464,969. This represents 0.11% of its overall portfolio holdings.

Number of Shares

4,925

Previous 11,096 55.61%

Holding current value

$464,969

Previous $761,000 45.86%

% of portfolio

0.11%

Previous 0.23%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $410,926 - $518,302	-6,171 Reduced 55.61%	4,925 $412,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $599,925 - $692,360	-9,500 Reduced 46.13%	11,096 $761,000
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $418,886 - $510,821	5,852 Added 39.69%	20,596 $1.51 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $770,214 - $873,442	10,512 Added 248.39%	14,744 $1.19 Million
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $4.01 Million - $4.38 Million	-54,287 Reduced 92.77%	4,232 $317,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $12,617 - $14,392	-166 Reduced 0.28%	58,519 $4.51 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $250,329 - $285,203	3,238 Added 5.84%	58,685 $4.87 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $21,438 - $30,777	344 Added 0.62%	55,447 $4.76 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $304,547 - $347,871	5,115 Added 10.23%	55,103 $3.4 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $921,788 - $1.04 Million	15,970 Added 46.95%	49,988 $3.09 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $848,470 - $1.06 Million	14,649 Added 75.63%	34,018 $2.02 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $1.05 Million - $1.19 Million	16,216 Added 514.3%	19,369 $1.41 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $426,176 - $459,796	-6,296 Reduced 66.63%	3,153 $220,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $568,945 - $621,653	-8,964 Reduced 48.68%	9,449 $651,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $146,100 - $166,700	-2,435 Reduced 11.68%	18,413 $1.19 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $356,498 - $406,213	-6,293 Reduced 23.19%	20,848 $1.22 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $47,941 - $60,277	772 Added 2.93%	27,141 $1.72 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $604,907 - $702,408	-8,362 Reduced 24.08%	26,369 $2.03 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $871,183 - $1.12 Million	13,910 Added 66.81%	34,731 $2.6 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $1.28 Million - $1.41 Million	20,821 New	20,821 $1.35 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on L2 Asset Management, LLC with notifications on news.

Account

L2 Asset Management, LLC Gilead Sciences, Inc. Transaction History